DGAP-News

STADA Arzneimittel AG: Figures for the first half of 2015 benefit from substantially improved development in Q2/2015 - Central Europe as well as Asia/Pacific & MENA with excellent development, CIS/Eastern Europe stabilized considerably - Seite 3

on linear extrapolation of the adjusted EBITDA of the reporting period on a
full-year basis (1-6/2014: 3.5).

Development of the market regions
The four STADA market regions developed as follows:

In the market region Central Europe, sales recorded an increase in the
reporting period - with varying development of the countries included - of
7 percent to Euro 499.1 million (1-6/2014: Euro 467.4 million). While sales
grew in the United Kingdom, Spain and Italy, sales in Belgium and France
declined. Overall, sales generated in this market region had a share of
48.7 percent in Group sales (1-6/2014: 46.6 percent).

In the market region Germany, sales in the first half of 2015 were
approximately at the same level of the corresponding period of the previous
year with Euro 227.9 million (1-6/2014: Euro 227.0 million). This
development was achieved despite the fact that export activities to the
MENA region are no longer disclosed in the market region Germany due to the
grouping together of activities from the MENA region and from the former
market region Asia & Pacific as of January 1, 2015. Overall, the market
region Germany contributed 22.2 percent to Group sales (1-6/2014: 22.6
percent).

In the market region CIS/Eastern Europe, sales in the first 6 months of the
current financial year rose by 3 percent applying the exchange rates of the
previous year. As a result of negative currency effects, sales in euro
recorded a decrease of 14 percent to Euro 227.2 million (1-6/2014:
Euro 265.6 million). Sales generated in this market region had a share of
22.1 percent in Group sales (1-6/2014: 26.5 percent). In Russia, sales
applying the exchange rates of the previous year were approximately at the
same level of the corresponding period of the previous year. As a result of
a clearly negative currency effect of the Russian ruble, sales reported in
euro were, with Euro 125.5 million, 23 percent below the performance of the
previous year (1-6/2014: Euro 163.5 million). In comparison to the sales
development in the first quarter of 2015 (-43 percent as compared to the
corresponding period of the previous year), however, this sales trend
stabilized considerably. In Serbia, sales increased by 9 percent applying
the exchange rates of the previous year. As a result of a negative currency
effect of the Serbian dinar, sales in euro recorded growth by 5 percent to
Euro 46.9 million (1-6/2014: Euro 44.8 million).

In the market region Asia/Pacific & MENA, sales in the period under review
showed an increase of 67 percent to Euro 71.7 million (1-6/2014: Euro 42.8